Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1409-1415

  Heyninck, Karen ^a   Wullaert, Andy ^a   Beyaert, Rudi ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Apoptosis; ConA; Concanavalin A; Galactosamine; GalN; Hepatitis; I kappa B kinase; IKK; IL; Interleukin; Lipopolysaccharide; Liver failure; LPS; NF B; Nuclear factor kappa B; Signal transduction; TNF; TNF R; TNF receptor; Tumour necrosis factor

Indexed keywords

A20 BINDING INHIBITOR OF NUCLEAR FACTOR KAPPA B ACTIVATION PROTEIN 1; ADENOVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PROTEIN DERIVATIVE; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN A20; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CANCER; CONFERENCE PAPER; DISEASE MODEL; DRUG TARGETING; GENE ACTIVATION; GENE EXPRESSION REGULATION; HEPATITIS; HUMAN; IN VIVO STUDY; INFLAMMATION; LIVER CELL; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY; ANIMAL; ANIMAL MODEL; CHEMICALLY INDUCED DISORDER; LIVER FAILURE; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; LIVER FAILURE; MODELS, ANIMAL; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0642375808     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00491-X     Document Type: Conference Paper

References (63)

1. Bernal W., Wendon J. Acute liver failure clinical features and management. Eur. J. Gastroenterol. Hepatol. 11:1999;977-984.
2. Gonzalez-Amaro R., Garcia-Monzon C., Garcia-Buey L., Moreno-Otero R., Alonso J.L., Yague E., Pivel J.P., Lopez-Cabrera M., Fernandez-Ruiz E., Sanchez-Madrid F. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179:1994;841-848.
3. Muto Y., Nouri-Aria K.T., Meager A., Alexander G.J., Eddleston A.L., Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. 2:1988;72-74.
4. Bird G.L., Sheron N., Goka A.K., Alexander G.J., Williams R.S. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 112:1990;917-920.
5. Diehl A.M., Rai R. Review: regulation of liver regeneration by pro-inflammatory cytokines. J. Gastroenterol. Hepatol. 11:1996;466-470.
6. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., Thurman R.G. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology. 26:1997;1530-1537.
7. Leist M., Gantner F., Bohlinger I., Tiegs G., Germann P.G., Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146:1995;1220-1234.
8. Leist M., Gantner F., Naumann H., Bluethmann H., Vogt K., Brigelius-Flohe R., Nicotera P., Volk H.D., Wendel A. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology. 112:1997;923-934.
9. Xu Y., Bialik S., Jones B.E., Iimuro Y., Kitsis R.N., Srinivasan A., Brenner D.A., Czaja M.J. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am. J. Physiol. 275:1998;C1058-C1066.
10. Larrea E., Garcia N., Qian C., Civeira M.P., Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 23:1996;210-217.
11. Zylberberg H., Rimaniol A.C., Pol S., Masson A., De Groote D., Berthelot P., Bach J.F., Brechot C., Zavala F. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J. Hepatol. 30:1999;185-191.
12. Zhu N., Ware C.F., Lai M.M. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology. 283:2001;178-187.
13. Zhu N., Khoshnan A., Schneider R., Matsumoto M., Dennert G., Ware C., Lai M.M. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72:1998;3691-3697.
14. Ray R.B., Meyer K., Steele R., Shrivastava A., Aggarwal B.B., Ray R. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 273:1998;2256-2259.
15. Majumder M., Ghosh A.K., Steele R., Zhou X.Y., Phillips N.J., Ray R., Ray R.B. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology. 294:2002;94-105.
16. Lasarte J.J., Sarobe P., Boya P., Casares N., Arribillaga L., De Cerio A.L., Gorraiz M., Borras-Cuesta F., Prieto J. A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage. Hepatology. 37:2003;461-470.
17. McClain C.J., Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 9:1989;349-351.
18. Grove J., Daly A.K., Bassendine M.F., Day C.P. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 26:1997;143-146.
19. Yamada Y., Kirillova I., Peschon J.J., Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1441-1446.
20. Santucci L., Fiorucci S., Chiorean M., Brunori P.M., Di Matteo F.M., Sidoni A., Migliorati G., Morelli A. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology. 111:1996;736-744.
21. Decker K., Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71:1974;77-106.
22. Van Molle W., Denecker G., Rodriguez I., Brouckaert P., Vandenabeele P., Libert C. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J. Immunol. 163:1999;5235-5241.
23. Leist M., Gantner F., Jilg S., Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154:1995;1307-1316.
24. Guicciardi M.E., Miyoshi H., Bronk S.F., Gores G.J. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am. J. Pathol. 159:2001;2045-2054.
25. Nowak M., Gaines G.C., Rosenberg J., Minter R., Bahjat F.R., Rectenwald J., MacKay S.L., Edwards C.K. III, Moldawer L.L. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R1202-R1209.
26. Leonis M.A., Toney-Earley K., Degen S.J., Waltz S.E. Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure. Hepatology. 36:2002;1053-1060.
27. Sass G., Koerber K., Bang R., Guehring H., Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 107:2001;439-447.
28. Tagawa Y., Sekikawa K., Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J. Immunol. 159:1997;1418-1428.
29. Gantner F., Leist M., Lohse A.W., Germann P.G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 21:1995;190-198.
30. Kusters S., Tiegs G., Alexopoulou L., Pasparakis M., Douni E., Kunstle G., Bluethmann H., Wendel A., Pfizenmaier K., Kollias G., Grell M. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27:1997;2870-2875.
31. Streetz K., Fregien B., Plumpe J., Korber K., Kubicka S., Sass G., Bischoff S.C., Manns M.P., Tiegs G., Trautwein C. Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure. J. Immunol. 167:2001;514-523.
32. Schumann J., Muhlen K., Kiemer A.K., Vollmar A.M., Tiegs G. Parenchymal, but not leukocyte, TNF receptor 2 mediates T cell-dependent hepatitis in mice. J. Immunol. 170:2003;2129-2137.
33. Beyaert R., Van Loo G., Heyninck K., Vandenabeele P. Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int. Rev. Cytol. 214:2002;225-272.
34. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., Kaufmann S.H., Gores G.J. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106:2000;1127-1137.
35. Garcia-Ruiz C., Colell A., Mari M., Morales A., Calvo M., Enrich C., Fernandez-Checa J.C. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J. Clin. Invest. 111:2003;197-208.
36. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:1995;167-170.
37. Alcamo E., Mizgerd J.P., Horwitz B.H., Bronson R., Beg A.A., Scott M., Doerschuk C.M., Hynes R.O., Baltimore D. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J. Immunol. 167:2001;1592-1600.
38. Doi T.S., Marino M.W., Takahashi T., Yoshida T., Sakakura T., Old L.J., Obata Y. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2994-2999.
39. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1999;1839-1845.
40. Rudolph D., Yeh W.C., Wakeham A., Rudolph B., Nallainathan D., Potter J., Elia A.J., Mak T.W. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14:2000;854-862.
41. Li Q., Van Antwerp D., Mercurio F., Lee K.F., Verma I.M. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 284:1999;321-325.
42. Bonnard M., Mirtsos C., Suzuki S., Graham K., Huang J., Ng M., Itie A., Wakeham A., Shahinian A., Henzel W.J., Elia A.J., Shillinglaw W., Mak T.W., Cao Z., Yeh W.C. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19:2000;4976-4985.
43. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 406:2000;86-90.
44. Mikula M., Schreiber M., Husak Z., Kucerova L., Ruth J., Wieser R., Zatloukal K., Beug H., Wagner E.F., Baccarini M. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20:2001;1952-1962.
45. Nishina H., Vaz C., Billia P., Nghiem M., Sasaki T., De la Pompa J.L., Furlonger K., Paige C., Hui C., Fischer K.D., Kishimoto H., Iwatsubo T., Katada T., Woodgett J.R., Penninger J.M. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development. 126:1999;505-516.
46. Sanjo H., Takeda K., Tsujimura T., Ninomiya-Tsuji J., Matsumoto K., Akira S. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol. Cell. Biol. 23:2003;1231-1238.
47. Hilberg F., Aguzzi A., Howells N., Wagner E.F. c-jun is essential for normal mouse development and hepatogenesis. Nature. 365:1993;179-181.
48. Lavon I., Goldberg I., Amit S., Landsman L., Jung S., Tsuberi B.Z., Barshack I., Kopolovic J., Galun E., Bujard H., Ben-Neriah Y. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat. Med. 6:2000;573-577.
49. Iimuro Y., Nishiura T., Hellerbrand C., Behrns K.E., Schoonhoven R., Grisham J.W., Brenner D.A. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101:1998;802-811.
50. Libert C., Van Bladel S., Brouckaert P., Shaw A., Fiers W. Involvement of the liver but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J. Immunol. 146:1991;2625-2632.
51. Nagaki M., Naiki T., Brenner D.A., Osawa Y., Imose M., Hayashi H., Banno Y., Nakashima S., Moriwaki H. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis but not fas-mediated apoptosis: role of nuclear factor-kappaB. Hepatology. 32:2000;1272-1279.
52. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107:2001;241-246.
53. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., Cong R., Franzoso G. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature. 414:2001;308-313.
54. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature. 414:2001;313-317.
55. Liu H., Lo C.R., Czaja M.J. NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology. 35:2002;772-778.
56. Trautwein C., Rakemann T., Brenner D.A., Streetz K., Licato L., Manns M.P., Tiegs G. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology. 114:1998;1035-1045.
57. Liedtke C., Plumpe J., Kubicka S., Bradham C.A., Manns M.P., Brenner D.A., Trautwein C. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells. Hepatology. 36:2002;315-325.
58. Schoemaker M.H., Ros J.E., Homan M., Trautwein C., Liston P., Poelstra K., van Goor H., Jansen P.L., Moshage H. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J. Hepatol. 36:2002;742-750.
59. Seino K., Setoguchi Y., Ogino T., Kayagaki N., Akiba H., Nakano H., Taniguchi H., Takada Y., Yuzawa K., Todoroki T., Fukuchi Y., Yagita H., Okumura K., Fukao K. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation. Ann. Surg. 234:2001;681-688.
60. Beyaert R., Heyninck K., Van Huffel S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60:2000;1143-1151.
61. Heyninck K., De Valck D., Vanden Berghe W., Van Criekinge W., Contreras R., Fiers W., Haegeman G., Beyaert R. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J. Cell Biol. 145:1999;1471-1482.
62. Arvelo M.B., Cooper J.T., Longo C., Daniel S., Grey S.T., Mahiou J., Czismadia E., Abu-Jawdeh G., Ferran C. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology. 35:2002;535-543.
63. Heyninck K., Kreike M.M., Beyaert R. Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1. FEBS Lett. 536:2003;135-140.